Published in Blood Weekly, December 2nd, 2004
The official approval is anticipated within 3 months. The EMEA and CHMP operate similarly to the U.S. Food & Drug Administration (FDA) and the FDA's advisory boards in reviewing and commenting on new products before they are approved for sale.
GSK Bio has a long history and commitment to the successful...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.